Silo Pharma (SILO) Financial Statements

224 Followers

Silo Pharma Financial Overview

Silo Pharma's market cap is currently $4.88M. The company's EPS TTM is $-5.353; its P/E ratio is -0.57; Silo Pharma is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	$ 72.10K	$ 72.10K	$ 72.10K	$ 72.10K	$ 71.26K
Gross Profit	$ -813.96K	$ 66.26K	$ 66.26K	$ 66.26K	$ 66.26K
Operating Income	$ -4.28M	$ -4.71M	$ -3.86M	$ -3.63M	$ -2.74M
EBITDA	$ -4.18M	$ -4.38M	$ -3.63M	$ -3.91M	$ 4.19M
Net Income	$ -4.23M	$ -4.39M	$ -3.70M	$ -3.91M	$ 3.90M
Balance Sheet
Cash & Short-Term Investments	$ 6.86M	$ 7.08M	$ 7.67M	$ 11.37M	$ 10.26M
Total Assets	$ 7.61M	$ 7.41M	$ 7.75M	$ 11.64M	$ 10.49M
Total Debt	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Net Debt	$ -4.75M	$ -3.91M	$ -3.52M	$ -11.37M	$ -9.84M
Total Liabilities	$ 1.30M	$ 2.38M	$ 1.57M	$ 1.30M	$ 1.43M
Stockholders' Equity	$ 6.31M	$ 5.03M	$ 6.18M	$ 10.34M	$ 9.06M
Cash Flow
Free Cash Flow	$ -4.66M	$ -3.83M	$ -3.22M	$ -3.50M	$ -2.28M
Operating Cash Flow	$ -4.66M	$ -3.83M	$ -3.22M	$ -3.50M	$ -2.28M
Investing Cash Flow	$ 644.02K	$ 973.78K	$ -4.15M	$ 86.71K	$ 7.19M
Financing Cash Flow	$ 4.86M	$ 3.24M	$ -471.12K	$ 4.94M	$ 3.79M

Currency in USD

Silo Pharma Earnings and Revenue History

Income Statement >

Silo Pharma Debt to Assets

Balance Sheet >

Silo Pharma Cash Flow

Cash Flow >

Silo Pharma Forecast EPS vs Actual EPS

Earnings >